NO961841L - Antitrombotiske amidinofenylalanin- og amidinopyridylalaninderivater - Google Patents
Antitrombotiske amidinofenylalanin- og amidinopyridylalaninderivaterInfo
- Publication number
- NO961841L NO961841L NO961841A NO961841A NO961841L NO 961841 L NO961841 L NO 961841L NO 961841 A NO961841 A NO 961841A NO 961841 A NO961841 A NO 961841A NO 961841 L NO961841 L NO 961841L
- Authority
- NO
- Norway
- Prior art keywords
- conr5r6
- pct
- optionally substituted
- alkyl
- nr5r6
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyurethanes Or Polyureas (AREA)
- Treating Waste Gases (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939322976A GB9322976D0 (en) | 1993-11-08 | 1993-11-08 | Therapeutic agents |
| PCT/EP1994/003509 WO1995013274A1 (fr) | 1993-11-08 | 1994-10-24 | Derives antithrombotiques d'amidinophenylalanine et d'amidinopyridylalanine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961841D0 NO961841D0 (no) | 1996-05-07 |
| NO961841L true NO961841L (no) | 1996-05-07 |
Family
ID=10744811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961841A NO961841L (no) | 1993-11-08 | 1996-05-07 | Antitrombotiske amidinofenylalanin- og amidinopyridylalaninderivater |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US5750520A (fr) |
| EP (1) | EP0728132B1 (fr) |
| JP (1) | JP2739776B2 (fr) |
| KR (1) | KR960705807A (fr) |
| CN (1) | CN1134148A (fr) |
| AT (1) | ATE155464T1 (fr) |
| AU (1) | AU680565B2 (fr) |
| CA (1) | CA2176037C (fr) |
| CO (1) | CO4290420A1 (fr) |
| CZ (1) | CZ282359B6 (fr) |
| DE (1) | DE69404325T2 (fr) |
| DK (1) | DK0728132T3 (fr) |
| ES (1) | ES2105868T3 (fr) |
| FI (1) | FI112481B (fr) |
| GB (1) | GB9322976D0 (fr) |
| GR (1) | GR3024228T3 (fr) |
| HU (1) | HUT76268A (fr) |
| IL (1) | IL111478A0 (fr) |
| NO (1) | NO961841L (fr) |
| NZ (1) | NZ275798A (fr) |
| PE (1) | PE22795A1 (fr) |
| PL (1) | PL314237A1 (fr) |
| SG (1) | SG52218A1 (fr) |
| WO (1) | WO1995013274A1 (fr) |
| ZA (1) | ZA948772B (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522495D0 (en) * | 1995-11-02 | 1996-01-03 | Pfizer Ltd | Therapeutic agents |
| US7109326B2 (en) | 1997-04-15 | 2006-09-19 | Genentech, Inc. | Halo-alkoxycarbonyl prodrugs |
| IL123986A (en) | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
| US6740682B2 (en) | 1997-08-29 | 2004-05-25 | Tularik Limited | Meta-benzamidine derivatives as serine protease inhibitors |
| DE69830410T2 (de) * | 1997-08-29 | 2006-01-26 | Tularik Ltd. | Meta-benzamidinderivate als serinprotease-inhibitoren |
| WO1999016752A1 (fr) * | 1997-09-30 | 1999-04-08 | Molecular Designs International, Inc. | AGONISTES DE β3-ADRENORECEPTEURS, COMPOSITIONS D'AGONISTES ET PROCEDES D'UTILISATION |
| PT997474E (pt) | 1998-08-14 | 2004-01-30 | Pfizer | Agentes antitromboticos |
| WO2001087834A1 (fr) * | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Antagoniste de l'hormone de concentration de la melanine |
| SI20743A (sl) | 2000-12-22 | 2002-06-30 | Univerza V Ljubljani, | Novi trombinski inhibitorji |
| US6593341B2 (en) | 2001-03-29 | 2003-07-15 | Molecular Design International, Inc. | β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same |
| SI21137A (sl) * | 2002-01-24 | 2003-08-31 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Derivati azafenilalanina |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| AU2003265398A1 (en) * | 2002-08-09 | 2004-02-25 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds and methods to modulate coagulation |
| US6596734B1 (en) | 2002-10-11 | 2003-07-22 | Molecular Design International, Inc. | Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists |
| EP2189448B1 (fr) | 2003-06-17 | 2014-01-29 | Arena Pharmaceuticals, Inc. | Procédés de séparation de racemates de 3-Benzazepines |
| CN101792417A (zh) * | 2003-06-17 | 2010-08-04 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物 |
| US7501538B2 (en) * | 2003-08-08 | 2009-03-10 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
| CN1832920A (zh) * | 2003-08-08 | 2006-09-13 | 特兰斯泰克制药公司 | 芳基和杂芳基化合物,组合物及其使用方法 |
| US7208601B2 (en) * | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
| US20080009478A1 (en) * | 2003-10-22 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| US20070275949A1 (en) * | 2003-10-22 | 2007-11-29 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases |
| KR101281919B1 (ko) | 2004-12-21 | 2013-07-03 | 아레나 파마슈티칼스, 인크. | (ｒ)-8-클로로-1-메틸-2,3,4,5-테트라히드로-1ｈ-3-벤즈아제핀 히드로클로라이드의 결정질 형태 |
| PT1833473E (pt) | 2004-12-23 | 2009-12-17 | Arena Pharm Inc | Composições de modulador de receptor 5ht2c e métodos de utilização |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| GB0523539D0 (en) * | 2005-11-18 | 2005-12-28 | Lek Tovarna Farmacevtskih | New use of organic compounds |
| EP2001852A2 (fr) | 2006-04-03 | 2008-12-17 | Arena Pharmaceuticals, Inc. | Procédés de préparation de 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine et produits intermédiaires associés |
| TWI389899B (zh) * | 2006-08-08 | 2013-03-21 | Msd Oss Bv | 具口服活性之凝血酶抑制劑 |
| CA2670285A1 (fr) | 2006-12-05 | 2008-06-12 | Arena Pharmaceuticals, Inc. | Procedes de preparation de (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine et intermediaires de celle-ci |
| WO2009103440A1 (fr) * | 2008-02-21 | 2009-08-27 | Sanofi-Aventis | Chlorothiophène-amides utilisés comme inhibiteurs des facteurs de coagulation xa et de la thrombine |
| EP2280964B1 (fr) * | 2008-02-21 | 2012-08-29 | Sanofi | Chlorothiophène-isoxazoles utilisés comme inhibiteurs du facteur de coagulation xa et de thrombine |
| JP5491421B2 (ja) * | 2008-03-04 | 2014-05-14 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス |
| CN102648170A (zh) | 2009-06-18 | 2012-08-22 | 艾尼纳制药公司 | 制备5-ht2c受体激动剂的方法 |
| AR080375A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida |
| US9045431B2 (en) | 2010-06-02 | 2015-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| CN103189360A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 5-ht2c激动剂的非吸湿性盐 |
| ES2704455T3 (es) | 2010-09-01 | 2019-03-18 | Arena Pharm Inc | Formas farmacéuticas de liberación modificada de agonistas de 5-HT2C útiles para la gestión del peso |
| EP2939677A1 (fr) | 2010-09-01 | 2015-11-04 | Arena Pharmaceuticals, Inc. | Administration de lorcasérine à des individus avec une insuffisance rénale |
| WO2012030938A1 (fr) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Sels de lorcasérine dotés d'acides optiquement actifs |
| AU2012392187B2 (en) | 2012-10-09 | 2018-07-12 | Arena Pharmaceuticals, Inc. | Method of weight management |
| WO2018213150A1 (fr) | 2017-05-15 | 2018-11-22 | Mitobridge, Inc. | Inhibiteurs de usp30 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0511347A1 (fr) * | 1990-11-15 | 1992-11-04 | Pentapharm A.G. | Derives de la phenylalanine metasubstitues |
-
1993
- 1993-11-08 GB GB939322976A patent/GB9322976D0/en active Pending
-
1994
- 1994-10-24 CZ CZ961322A patent/CZ282359B6/cs unknown
- 1994-10-24 JP JP7513554A patent/JP2739776B2/ja not_active Expired - Fee Related
- 1994-10-24 EP EP95900087A patent/EP0728132B1/fr not_active Expired - Lifetime
- 1994-10-24 PL PL94314237A patent/PL314237A1/xx unknown
- 1994-10-24 DE DE69404325T patent/DE69404325T2/de not_active Expired - Fee Related
- 1994-10-24 HU HU9601229A patent/HUT76268A/hu unknown
- 1994-10-24 WO PCT/EP1994/003509 patent/WO1995013274A1/fr active IP Right Grant
- 1994-10-24 ES ES95900087T patent/ES2105868T3/es not_active Expired - Lifetime
- 1994-10-24 NZ NZ275798A patent/NZ275798A/en unknown
- 1994-10-24 CN CN94194003A patent/CN1134148A/zh active Pending
- 1994-10-24 CA CA002176037A patent/CA2176037C/fr not_active Expired - Fee Related
- 1994-10-24 SG SG1996000579A patent/SG52218A1/en unknown
- 1994-10-24 AT AT95900087T patent/ATE155464T1/de not_active IP Right Cessation
- 1994-10-24 KR KR1019960702386A patent/KR960705807A/ko not_active Application Discontinuation
- 1994-10-24 DK DK95900087.8T patent/DK0728132T3/da active
- 1994-10-24 US US08/628,642 patent/US5750520A/en not_active Expired - Fee Related
- 1994-10-24 AU AU81049/94A patent/AU680565B2/en not_active Expired - Fee Related
- 1994-10-31 IL IL11147894A patent/IL111478A0/xx unknown
- 1994-11-02 PE PE1994253992A patent/PE22795A1/es not_active Application Discontinuation
- 1994-11-04 CO CO94050730A patent/CO4290420A1/es unknown
- 1994-11-07 ZA ZA948772A patent/ZA948772B/xx unknown
-
1996
- 1996-05-07 NO NO961841A patent/NO961841L/no unknown
- 1996-05-07 FI FI961939A patent/FI112481B/fi active
-
1997
- 1997-07-23 GR GR970401874T patent/GR3024228T3/el unknown
- 1997-07-30 US US08/902,917 patent/US5861393A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CO4290420A1 (es) | 1996-04-17 |
| HUT76268A (en) | 1997-07-28 |
| IL111478A0 (en) | 1994-12-29 |
| PE22795A1 (es) | 1995-08-15 |
| EP0728132A1 (fr) | 1996-08-28 |
| GB9322976D0 (en) | 1994-01-05 |
| FI112481B (fi) | 2003-12-15 |
| WO1995013274A1 (fr) | 1995-05-18 |
| CA2176037C (fr) | 1999-07-13 |
| CZ282359B6 (cs) | 1997-07-16 |
| ZA948772B (en) | 1996-05-07 |
| PL314237A1 (en) | 1996-09-02 |
| FI961939A (fi) | 1996-05-07 |
| DE69404325T2 (de) | 1997-10-30 |
| CA2176037A1 (fr) | 1995-05-18 |
| US5750520A (en) | 1998-05-12 |
| NZ275798A (en) | 1997-09-22 |
| JPH09500391A (ja) | 1997-01-14 |
| NO961841D0 (no) | 1996-05-07 |
| DE69404325D1 (de) | 1997-08-21 |
| ES2105868T3 (es) | 1997-10-16 |
| AU680565B2 (en) | 1997-07-31 |
| AU8104994A (en) | 1995-05-29 |
| CZ132296A3 (en) | 1996-08-14 |
| EP0728132B1 (fr) | 1997-07-16 |
| SG52218A1 (en) | 1998-09-28 |
| GR3024228T3 (en) | 1997-10-31 |
| CN1134148A (zh) | 1996-10-23 |
| KR960705807A (ko) | 1996-11-08 |
| US5861393A (en) | 1999-01-19 |
| DK0728132T3 (da) | 1997-09-01 |
| JP2739776B2 (ja) | 1998-04-15 |
| HU9601229D0 (en) | 1996-07-29 |
| FI961939A0 (fi) | 1996-05-07 |
| ATE155464T1 (de) | 1997-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69404325D1 (de) | Antithrombotische amidinophenylalanin- und amidinopyridylalanin-derivate | |
| GR3033070T3 (en) | Antithrombotic amidinotetrahydropyridylalanine derivatives | |
| DE60221391D1 (de) | Substituierte indolsäurederivate als inhibitoren von plasminogen-aktivator-inhibitor-1 (pai-1) | |
| ATE411288T1 (de) | Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) | |
| EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| NZ333394A (en) | Amidino derivatives and their use as thrombin inhibitors | |
| WO2005042533A3 (fr) | Compose 2-cyanopyrrolidinecarboxamide | |
| ATE331709T1 (de) | Substituierte 3-carbonyl-1-yl essigsäure derivate als plasminogen aktivator inhibitor(pai-1) inhibitoren | |
| ATE261939T1 (de) | Amidinoderivate und ihre verwendung als thrombin- inhibitoren | |
| EP0645382A4 (fr) | Derive de coumarine et son utilisation. | |
| ATE407116T1 (de) | Neue amidino-derivate und deren verwendung als thrombin-inhibitoren | |
| MX9708278A (es) | Derivados de amidinotetrahidropiridilalanina, procedimiento para su preparacion y uso de los mismos. | |
| MX9803498A (es) | Derivados de n-amidino piperidina y benzamidina antitromboticos. | |
| RS20050514A (en) | Compounds having prolyl oligopeptidase inhibitory activity | |
| EA200300059A1 (ru) | Комбинированная противоопухолевая терапия, включающая применение производных замещенного акрилоилдистамицина, таксанов и/или антиметаболитов | |
| ECSP961723A (es) | Derivados de amidinotetrahidropiridilalanina antitromboticos | |
| KR950700897A (ko) | 옥소-및 히드록시-치환된 탄화수소의 아민 유도체(Amine Derivatives of oxo- and hydroxy-substituted hydrocarbons) |